Probenecid
Polycillin-prb, Probalan, Probampacin, Probenecid (probenecid) is a small molecule pharmaceutical. Probenecid was first approved as Principen w/ probenecid on 1982-01-01. It is used to treat gonorrhea, gout, and neurosyphilis in the USA. The pharmaceutical is active against solute carrier family 22 member 6. In addition, it is known to target solute carrier organic anion transporter family member 1C1 and transient receptor potential cation channel subfamily V member 2.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Ampicillin
+
Ampicillin trihydrate
+
Probenecid
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| PRINCIPEN W/ PROBENECID | Bristol Myers Squibb | N-050488 DISCN | 1982-01-01 | 1 products |
| POLYCILLIN-PRB | Bristol Myers Squibb | N-050457 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Colchicine
+
Probenecid
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| COLBENEMID | Merck KGaA | N-012383 DISCN | 1982-01-01 | 1 products, RLD |
Hide discontinued
Probenecid
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| BENEMID | Merck KGaA | N-007898 DISCN | 1982-01-01 | 1 products, RLD |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| probenecid and colchicine | ANDA | 2023-11-06 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| gonorrhea | DOID_7551 | D006069 | A54 |
| gout | EFO_0004274 | D006073 | M10 |
| neurosyphilis | EFO_0007339 | D009494 | A50.4 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
61 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hiv infections | D015658 | EFO_0000764 | B20 | 1 | 1 | — | 1 | 5 | 8 |
| Cytomegalovirus retinitis | D017726 | EFO_1001302 | — | 1 | 1 | — | 1 | 2 | 5 |
| Drug interactions | D004347 | — | — | 2 | — | — | 1 | — | 3 |
| Human influenza | D007251 | EFO_0007328 | J11.1 | — | — | — | 1 | — | 1 |
| Epilepsy | D004827 | EFO_0000474 | G40.9 | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Urinary tract infections | D014552 | EFO_0003103 | N39.0 | 1 | — | 3 | — | 1 | 5 |
| Obesity | D009765 | EFO_0001073 | E66.9 | 1 | 1 | 1 | — | — | 3 |
| Intraabdominal infections | D059413 | — | — | 1 | — | 1 | — | — | 2 |
| Cellulitis | D002481 | EFO_0003035 | L03.90 | — | 1 | 1 | — | — | 2 |
| Blood pressure | D001794 | EFO_0004325 | — | — | — | 1 | — | — | 1 |
| Overweight | D050177 | — | E66.3 | — | — | 1 | — | — | 1 |
| Heart failure | D006333 | HP_0001635 | I50 | — | 1 | 1 | — | — | 1 |
| Cystitis | D003556 | EFO_1000025 | N30 | — | — | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Bacterial infections | D001424 | — | A49 | 1 | 1 | — | — | 1 | 2 |
| Prehypertension | D058246 | — | — | — | 1 | — | — | — | 1 |
| Hyperuricemia | D033461 | HP_0002149 | — | — | 1 | — | — | — | 1 |
| Systolic heart failure | D054143 | EFO_1001207 | I50.20 | — | 1 | — | — | — | 1 |
| Traumatic brain injuries | D000070642 | — | S06 | 1 | 1 | — | — | — | 1 |
| Substance withdrawal syndrome | D013375 | EFO_0005800 | — | — | 1 | — | — | — | 1 |
| Substance-related disorders | D019966 | EFO_0003890 | F13 | — | 1 | — | — | — | 1 |
| Chronic pain | D059350 | HP_0012532 | — | — | 1 | — | — | — | 1 |
| Covid-19 | D000086382 | — | U07.1 | — | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 9 | — | — | — | — | 9 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 3 | — | — | — | — | 3 |
| Pyelonephritis | D011704 | EFO_1001141 | N10-N16 | 1 | — | — | — | 1 | 2 |
| Pharmacokinetics | D010599 | — | — | 1 | — | — | — | — | 1 |
| Cytomegalovirus infections | D003586 | EFO_0001062 | B25 | 1 | — | — | — | — | 1 |
| Neoplasms | D009369 | — | C80 | 1 | — | — | — | — | 1 |
| Alcoholism | D000437 | EFO_0003829 | F10.1 | 1 | — | — | — | — | 1 |
| Chondrocalcinosis | D002805 | HP_0000934 | M11.2 | 1 | — | — | — | — | 1 |
| Congenital syphilis | D013590 | EFO_0007219 | A50 | 1 | — | — | — | — | 1 |
| Renal insufficiency | D051437 | HP_0000083 | N19 | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Breast milk expression | D061186 | — | — | — | — | — | — | 1 | 1 |
| Progressive multifocal leukoencephalopathy | D007968 | EFO_0007455 | A81.2 | — | — | — | — | 1 | 1 |
| Gout | D006073 | EFO_0004274 | M10 | — | — | — | — | 1 | 1 |
| Kidney diseases | D007674 | EFO_0003086 | N08 | — | — | — | — | 1 | 1 |
| Surgical wound | D000072836 | — | — | — | — | — | — | 1 | 1 |
| Peritonsillar abscess | D000039 | EFO_0007429 | J36 | — | — | — | — | 1 | 1 |
| Ear diseases | D004427 | EFO_1001455 | H93.9 | — | — | — | — | 1 | 1 |
| Renal elimination | D065667 | — | — | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Probenecid |
| INN | probenecid |
| Description | Probenecid is a sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups. It has a role as a uricosuric drug. It is a sulfonamide and a member of benzoic acids. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1 |
Identifiers
| PDB | — |
| CAS-ID | 57-66-9 |
| RxCUI | — |
| ChEMBL ID | CHEMBL897 |
| ChEBI ID | 8426 |
| PubChem CID | 4911 |
| DrugBank | DB01032 |
| UNII ID | PO572Z7917 (ChemIDplus, GSRS) |
Target
Agency Approved
SLC22A6
SLC22A6
Organism
Homo sapiens
Gene name
SLC22A6
Gene synonyms
OAT1, PAHT
NCBI Gene ID
Protein name
solute carrier family 22 member 6
Protein synonyms
hOAT1, hPAHT, hROAT1, Organic anion transporter 1, PAH transporter, para-aminohippurate transporter, Renal organic anion transporter 1, solute carrier family 22 (organic anion transporter), member 6
Uniprot ID
Mouse ortholog
Slc22a6 (18399)
solute carrier family 22 member 6 (Q8VC69)
Alternate
SLCO1C1
SLCO1C1
TRPV2
TRPV2
Organism
Homo sapiens
Gene name
SLCO1C1
Gene synonyms
OATP14, OATP1C1, OATPF, SLC21A14
NCBI Gene ID
Protein name
solute carrier organic anion transporter family member 1C1
Protein synonyms
OAT-RP-5, OATP-14, OATP-F, OATP-RP5, OATP1C1, Organic anion transporter 1C1, Organic anion transporter F, Organic anion transporter polypeptide-related protein 5, organic anion transporting polypeptide 14, Organic anion-transporting polypeptide 14, solute carrier family 21 (organic anion transporter), member 14, Solute carrier family 21 member 14, Thyroxine transporter
Uniprot ID
Mouse ortholog
Slco1c1 (58807)
solute carrier organic anion transporter family member 1C1 (Q9ERB5)
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
Probenecid
+
Colchicine
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Probenecid
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 10,386 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
223 adverse events reported
View more details
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use